Taysha Gene Therapies, Inc. · NASDAQ:TSHA
Taysha Gene Therapies, Inc. shareholders
As of Jun 30, 2026, 201 institutions reported holding Taysha Gene Therapies, Inc., 91.9% of its shares. Largest: Avoro Capital Advisors LLC, Ra Capital Management, L.P. and Goldman Sachs. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Taysha Gene Therapies, Inc. | Change | Filed |
|---|---|---|---|---|
| Avoro Capital Advisors LLC | 23.9M | 7.3% | +2.19M | Aug 14, 2026 |
| Ra Capital Management, L.P. | 23.6M | 7.2% | no change | Aug 14, 2026 |
| Goldman Sachs | 22.7M | 7.0% | +343K | Aug 14, 2026 |
| BlackRock | 20.7M | 6.4% | +2.33M | Aug 7, 2026 |
| Vestal Point Capital, LP | 19.4M | 6.0% | +1.42M | Aug 14, 2026 |
| Vanguard | 17.8M | 5.5% | +3.79M | Aug 13, 2026 |
| Morgan Stanley | 16.5M | 5.1% | −1.48M | Aug 13, 2026 |
| Rtw Investments, LP | 13.6M | 4.2% | −120K | Aug 14, 2026 |
| Fidelity | 13.3M | 4.1% | −985K | Aug 13, 2026 |
| State Street | 11.4M | 3.5% | +213K | Aug 7, 2026 |